Aurora Cannabis Inc. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Aurora Cannabis Inc. on February 10, 2022, covering the reporting period for the three and six months ended December 31, 2021. The filing serves to distribute the company's Condensed Consolidated Interim Financial Statements and Interim Management's Discussion and Analysis (MD&A) to U.S. investors.
Key Financial Metrics
The filing text provided is a cover sheet and does not contain specific numerical data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this excerpt. These figures are located in the attached exhibits (Exhibit 99.1 and 99.2) referenced in the filing.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. The document indicates that comparative data for the three and six months ended December 31, 2020, is included in the attached financial statements and MD&A.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, risk factors, and contingencies are not detailed in the cover sheet. This information is contained within the Interim Management's Discussion and Analysis (Exhibit 99.2) submitted with this report.
Investor Verification Checklist
- Review Exhibit 99.1 for specific revenue, net loss, and cash flow figures for the six months ended December 31, 2021.
- Examine Exhibit 99.2 for management's discussion of operational performance and liquidity position.
- Verify the company's debt obligations and working capital status as detailed in the interim financial statements.
- Check for any updates on regulatory approvals or market expansion strategies mentioned in the MD&A.